Tuberculosis Testing and Diagnostics Market

1 Market Overview

1.1 Product Overview and Scope of Tuberculosis Testing and Diagnostics

1.2 Classification of Tuberculosis Testing and Diagnostics by Type

1.2.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2020

1.2.3 Smear Microscopy

1.2.4 Nucleic Acid Testing

1.2.5 Radiography

1.2.6 Tuberculin Skin Test (TST)

1.2.7 Interferon Gamma Released Assay (IGRA)

1.2.8 Others

1.3 Global Tuberculosis Testing and Diagnostics Market by Application

1.3.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Global Tuberculosis Testing and Diagnostics Market Size & Forecast

1.5 Global Tuberculosis Testing and Diagnostics Market Size and Forecast by Region

1.5.1 Global Tuberculosis Testing and Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Tuberculosis Testing and Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America Tuberculosis Testing and Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe Tuberculosis Testing and Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America Tuberculosis Testing and Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Tuberculosis Testing and Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Tuberculosis Testing and Diagnostics Market Drivers

1.6.2 Tuberculosis Testing and Diagnostics Market Restraints

1.6.3 Tuberculosis Testing and Diagnostics Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Tuberculosis Testing and Diagnostics Product and Solutions

2.1.4 Roche Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Roche Recent Developments and Future Plans

2.2 Thermo Fischer Scientific

2.2.1 Thermo Fischer Scientific Details

2.2.2 Thermo Fischer Scientific Major Business

2.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions

2.2.4 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Thermo Fischer Scientific Recent Developments and Future Plans

2.3 Becton Dickinson

2.3.1 Becton Dickinson Details

2.3.2 Becton Dickinson Major Business

2.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions

2.3.4 Becton Dickinson Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Becton Dickinson Recent Developments and Future Plans

2.4 Abbott

2.4.1 Abbott Details

2.4.2 Abbott Major Business

2.4.3 Abbott Tuberculosis Testing and Diagnostics Product and Solutions

2.4.4 Abbott Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Abbott Recent Developments and Future Plans

2.5 Hologic

2.5.1 Hologic Details

2.5.2 Hologic Major Business

2.5.3 Hologic Tuberculosis Testing and Diagnostics Product and Solutions

2.5.4 Hologic Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Hologic Recent Developments and Future Plans

2.6 Qiagen

2.6.1 Qiagen Details

2.6.2 Qiagen Major Business

2.6.3 Qiagen Tuberculosis Testing and Diagnostics Product and Solutions

2.6.4 Qiagen Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Qiagen Recent Developments and Future Plans

2.7 Sanofi

2.7.1 Sanofi Details

2.7.2 Sanofi Major Business

2.7.3 Sanofi Tuberculosis Testing and Diagnostics Product and Solutions

2.7.4 Sanofi Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Sanofi Recent Developments and Future Plans

2.8 Oxford Immunotec

2.8.1 Oxford Immunotec Details

2.8.2 Oxford Immunotec Major Business

2.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions

2.8.4 Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Oxford Immunotec Recent Developments and Future Plans

2.9 BioMerieux

2.9.1 BioMerieux Details

2.9.2 BioMerieux Major Business

2.9.3 BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions

2.9.4 BioMerieux Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 BioMerieux Recent Developments and Future Plans

2.10 Par Sterile

2.10.1 Par Sterile Details

2.10.2 Par Sterile Major Business

2.10.3 Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions

2.10.4 Par Sterile Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Par Sterile Recent Developments and Future Plans

2.11 Bio-Rad Laboratories

2.11.1 Bio-Rad Laboratories Details

2.11.2 Bio-Rad Laboratories Major Business

2.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions

2.11.4 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.12 Akonni Biosystems

2.12.1 Akonni Biosystems Details

2.12.2 Akonni Biosystems Major Business

2.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions

2.12.4 Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Akonni Biosystems Recent Developments and Future Plans

2.13 Cepheid

2.13.1 Cepheid Details

2.13.2 Cepheid Major Business

2.13.3 Cepheid Tuberculosis Testing and Diagnostics Product and Solutions

2.13.4 Cepheid Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Cepheid Recent Developments and Future Plans

2.14 Siemens Healthineer

2.14.1 Siemens Healthineer Details

2.14.2 Siemens Healthineer Major Business

2.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions

2.14.4 Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Siemens Healthineer Recent Developments and Future Plans

2.15 Hain Lifescience

2.15.1 Hain Lifescience Details

2.15.2 Hain Lifescience Major Business

2.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions

2.15.4 Hain Lifescience Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Hain Lifescience Recent Developments and Future Plans

2.16 Epistem

2.16.1 Epistem Details

2.16.2 Epistem Major Business

2.16.3 Epistem Tuberculosis Testing and Diagnostics Product and Solutions

2.16.4 Epistem Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Epistem Recent Developments and Future Plans

2.17 Creative Diagnostics

2.17.1 Creative Diagnostics Details

2.17.2 Creative Diagnostics Major Business

2.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions

2.17.4 Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Creative Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Tuberculosis Testing and Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Tuberculosis Testing and Diagnostics Players Market Share

3.2.2 Top 10 Tuberculosis Testing and Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 Tuberculosis Testing and Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Tuberculosis Testing and Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2016-2021)

5.2 Tuberculosis Testing and Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Tuberculosis Testing and Diagnostics Revenue by Type (2016-2026)

6.2 North America Tuberculosis Testing and Diagnostics Revenue by Application (2016-2026)

6.3 North America Tuberculosis Testing and Diagnostics Market Size by Country

6.3.1 North America Tuberculosis Testing and Diagnostics Revenue by Country (2016-2026)

6.3.2 United States Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Tuberculosis Testing and Diagnostics Revenue by Type (2016-2026)

7.2 Europe Tuberculosis Testing and Diagnostics Revenue by Application (2016-2026)

7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Country

7.3.1 Europe Tuberculosis Testing and Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region

8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2016-2026)

8.3.2 China Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Tuberculosis Testing and Diagnostics Revenue by Type (2016-2026)

9.2 South America Tuberculosis Testing and Diagnostics Revenue by Application (2016-2026)

9.3 South America Tuberculosis Testing and Diagnostics Market Size by Country

9.3.1 South America Tuberculosis Testing and Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country

10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE Tuberculosis Testing and Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Tuberculosis Testing and Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Tuberculosis Testing and Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Tuberculosis Testing and Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Tuberculosis Testing and Diagnostics Product and Solutions

Table 9. Roche Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fischer Scientific Major Business

Table 12. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions

Table 13. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Becton Dickinson Corporate Information, Head Office, and Major Competitors

Table 15. Becton Dickinson Major Business

Table 16. Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions

Table 17. Becton Dickinson Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Abbott Corporate Information, Head Office, and Major Competitors

Table 19. Abbott Major Business

Table 20. Abbott Tuberculosis Testing and Diagnostics Product and Solutions

Table 21. Abbott Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Hologic Corporate Information, Head Office, and Major Competitors

Table 23. Hologic Major Business

Table 24. Hologic Tuberculosis Testing and Diagnostics Product and Solutions

Table 25. Hologic Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Qiagen Corporate Information, Head Office, and Major Competitors

Table 27. Qiagen Major Business

Table 28. Qiagen Tuberculosis Testing and Diagnostics Product and Solutions

Table 29. Qiagen Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Sanofi Corporate Information, Head Office, and Major Competitors

Table 31. Sanofi Major Business

Table 32. Sanofi Tuberculosis Testing and Diagnostics Product and Solutions

Table 33. Sanofi Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Oxford Immunotec Corporate Information, Head Office, and Major Competitors

Table 35. Oxford Immunotec Major Business

Table 36. Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions

Table 37. Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 39. BioMerieux Major Business

Table 40. BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions

Table 41. BioMerieux Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Par Sterile Corporate Information, Head Office, and Major Competitors

Table 43. Par Sterile Major Business

Table 44. Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions

Table 45. Par Sterile Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Bio-Rad Laboratories Major Business

Table 48. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions

Table 49. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Akonni Biosystems Corporate Information, Head Office, and Major Competitors

Table 51. Akonni Biosystems Major Business

Table 52. Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions

Table 53. Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Cepheid Corporate Information, Head Office, and Major Competitors

Table 55. Cepheid Major Business

Table 56. Cepheid Tuberculosis Testing and Diagnostics Product and Solutions

Table 57. Cepheid Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Siemens Healthineer Corporate Information, Head Office, and Major Competitors

Table 59. Siemens Healthineer Major Business

Table 60. Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions

Table 61. Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Hain Lifescience Corporate Information, Head Office, and Major Competitors

Table 63. Hain Lifescience Major Business

Table 64. Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions

Table 65. Hain Lifescience Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Epistem Corporate Information, Head Office, and Major Competitors

Table 67. Epistem Major Business

Table 68. Epistem Tuberculosis Testing and Diagnostics Product and Solutions

Table 69. Epistem Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Creative Diagnostics Corporate Information, Head Office, and Major Competitors

Table 71. Creative Diagnostics Major Business

Table 72. Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions

Table 73. Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 75. Global Tuberculosis Testing and Diagnostics Revenue Share by Players (2019-2021)

Table 76. Breakdown of Tuberculosis Testing and Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Tuberculosis Testing and Diagnostics Players Head Office, Products and Services Provided

Table 78. Tuberculosis Testing and Diagnostics Mergers & Acquisitions in the Past Five Years

Table 79. Tuberculosis Testing and Diagnostics New Entrants and Expansion Plans

Table 80. Global Tuberculosis Testing and Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 81. Global Tuberculosis Testing and Diagnostics Revenue Share by Type (2016-2021)

Table 82. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Type (2021-2026)

Table 83. Global Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021)

Table 84. Global Tuberculosis Testing and Diagnostics Revenue Forecast by Application (2021-2026)

Table 85. North America Tuberculosis Testing and Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 86. North America Tuberculosis Testing and Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 87. North America Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 88. North America Tuberculosis Testing and Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 89. North America Tuberculosis Testing and Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 90. North America Tuberculosis Testing and Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe Tuberculosis Testing and Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe Tuberculosis Testing and Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe Tuberculosis Testing and Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe Tuberculosis Testing and Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe Tuberculosis Testing and Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 103. South America Tuberculosis Testing and Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 104. South America Tuberculosis Testing and Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 105. South America Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 106. South America Tuberculosis Testing and Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 107. South America Tuberculosis Testing and Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 108. South America Tuberculosis Testing and Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Tuberculosis Testing and Diagnostics Picture

Figure 2. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2020

Figure 3. Smear Microscopy

Figure 4. Nucleic Acid Testing

Figure 5. Radiography

Figure 6. Tuberculin Skin Test (TST)

Figure 7. Interferon Gamma Released Assay (IGRA)

Figure 8. Others

Figure 9. Tuberculosis Testing and Diagnostics Revenue Market Share by Application in 2020

Figure 10. Hospitals and Clinics Picture

Figure 11. Diagnostic Laboratories Picture

Figure 12. Others Picture

Figure 13. Global Tuberculosis Testing and Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Tuberculosis Testing and Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2016-2026)

Figure 16. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Region in 2020

Figure 17. North America Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Tuberculosis Testing and Diagnostics Market Drivers

Figure 23. Tuberculosis Testing and Diagnostics Market Restraints

Figure 24. Tuberculosis Testing and Diagnostics Market Trends

Figure 25. Roche Recent Developments and Future Plans

Figure 26. Thermo Fischer Scientific Recent Developments and Future Plans

Figure 27. Becton Dickinson Recent Developments and Future Plans

Figure 28. Abbott Recent Developments and Future Plans

Figure 29. Hologic Recent Developments and Future Plans

Figure 30. Qiagen Recent Developments and Future Plans

Figure 31. Sanofi Recent Developments and Future Plans

Figure 32. Oxford Immunotec Recent Developments and Future Plans

Figure 33. BioMerieux Recent Developments and Future Plans

Figure 34. Par Sterile Recent Developments and Future Plans

Figure 35. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 36. Akonni Biosystems Recent Developments and Future Plans

Figure 37. Cepheid Recent Developments and Future Plans

Figure 38. Siemens Healthineer Recent Developments and Future Plans

Figure 39. Hain Lifescience Recent Developments and Future Plans

Figure 40. Epistem Recent Developments and Future Plans

Figure 41. Creative Diagnostics Recent Developments and Future Plans

Figure 42. Global Tuberculosis Testing and Diagnostics Revenue Share by Players in 2020

Figure 43. Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2020

Figure 45. Global Top 10 Players Tuberculosis Testing and Diagnostics Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Tuberculosis Testing and Diagnostics Revenue Share by Type in 2020

Figure 48. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Type (2021-2026)

Figure 49. Global Tuberculosis Testing and Diagnostics Revenue Share by Application in 2020

Figure 50. Global Tuberculosis Testing and Diagnostics Market Share Forecast by Application (2021-2026)

Figure 51. North America Tuberculosis Testing and Diagnostics Sales Market Share by Type (2016-2026)

Figure 52. North America Tuberculosis Testing and Diagnostics Sales Market Share by Application (2016-2026)

Figure 53. North America Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2016-2026)

Figure 54. United States Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Tuberculosis Testing and Diagnostics Sales Market Share by Type (2016-2026)

Figure 58. Europe Tuberculosis Testing and Diagnostics Sales Market Share by Application (2016-2026)

Figure 59. Europe Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2016-2026)

Figure 60. Germany Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Tuberculosis Testing and Diagnostics Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Tuberculosis Testing and Diagnostics Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Tuberculosis Testing and Diagnostics Revenue Market Share by Region (2016-2026)

Figure 68. China Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Tuberculosis Testing and Diagnostics Sales Market Share by Type (2016-2026)

Figure 75. South America Tuberculosis Testing and Diagnostics Sales Market Share by Application (2016-2026)

Figure 76. South America Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Tuberculosis Testing and Diagnostics Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Tuberculosis Testing and Diagnostics Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Tuberculosis Testing and Diagnostics Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Tuberculosis Testing and Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source